Sharon Brown
Adult Health · Vineland, NJNPI 1437487907
Payments from drug & device makers
Across 525 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- AbbVie$2K
- AstraZeneca$966
- GSK$569
- Pfizer$516
- Novo Nordisk$387
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 60 | $4,646 |
| AbbVie | 120 | $1,518 |
| AstraZeneca | 36 | $966 |
| GSK | 44 | $569 |
| Pfizer | 47 | $516 |
| Novo Nordisk | 39 | $387 |
| Biohaven Pharmaceutical Holding Company Ltd. | 21 | $348 |
| Lilly USA, LLC | 24 | $319 |
| Bayer | 14 | $284 |
| Amgen | 15 | $227 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $193 |
| Biohaven Pharmaceuticals, Inc. | 6 | $184 |
| Boehringer Ingelheim | 9 | $123 |
| Shield Therapeutics Inc | 2 | $110 |
| Kowa Pharmaceuticals America, Inc. | 7 | $104 |
| Daiichi Sankyo Inc. | 7 | $93 |
| Astellas Pharma US Inc | 6 | $92 |
| Merck | 6 | $89 |
| Lundbeck LLC | 5 | $80 |
| Nestle Healthcare Nutrition Inc. | 5 | $67 |
| Philips North America LLC | 4 | $65 |
| Idorsia Pharmaceuticals US Inc | 4 | $64 |
| Evoke Pharma, Inc. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Exact Sciences | 1 | $33 |
| Phathom Pharmaceuticals, Inc. | 3 | $30 |
| Eisai Inc. | 2 | $28 |
| Dexcom, Inc. | 2 | $25 |
| Seqirus USA Inc | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
How this compares
$11,393 in reported general payments places this provider in the 95th percentile of 1,135 adult health providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult health in Vineland
- June HalperHackensack$458K
- Kara SaggiomoCamden$127K
- Entela AhmetiPomona$75K
- Phyllis McKiernanHackensack$72K
- Denise ForceMiddletown$71K
- Kathleen SenecaHillsborough$64K
- Diane AndresenNorthvale$60K
- Dana BeenstockFreehold$51K
- Phyllis DudaCamden$46K
- Anthony WalkoWestwood$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.